Intralesional Mitomycin-C (MMC) injection has recently been introduced to resolve refractory benign esophageal stricture mostly in children. The investigators aimed to evaluate the clinical efficacy of endoscopic postdilation intralesional injection of MMC in adults with refractory benign esophageal stricture.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Initial clinical success of mitomycin C injection therapy
Timeframe: 12 months after mitomycin C injection
Overall clinical success of mitomycin C injection therapy
Timeframe: 12 months after mitomycin C injection